Rothschild Investment LLC’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.1K	Buy	140 +90	+180%	+$1.35K	﹤0.01%	2045
2025 Q1	$807	Buy	50 +10	+25%	+$161	﹤0.01%	2453
2024 Q4	$931	Hold	40	–	–	﹤0.01%	2256
2024 Q3	$1.18K	Buy	40 +35	+700%	+$1.03K	﹤0.01%	2051
2024 Q2	$118	Buy	+5	New	+$118	﹤0.01%	2684